The EMEA has issued a positive opinion recommending approval for Neupro (rotigotine) for moderate-to-severe idiopathic Restless Legs Syndrome (RLS) in adults. Neupro is already launched for Parkinson’s disease.
Filed under: Uncategorized | Tagged: agonist, Dopamine D3, Dopamne D2, Otsuka, rotigotine, UCB
